Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | STTK | Common Stock | Options Exercise | $16.3K | +4.65K | +5.86% | $3.51 | 84K | Mar 6, 2024 | Direct | |
transaction | STTK | Common Stock | Sale | -$49K | -4.65K | -5.54% | $10.53 | 79.3K | Mar 6, 2024 | Direct | F1 |
transaction | STTK | Common Stock | Options Exercise | $23.1K | +6.46K | +8.14% | $3.57 | 85.8K | Mar 6, 2024 | Direct | |
transaction | STTK | Common Stock | Sale | -$68K | -6.46K | -7.53% | $10.53 | 79.3K | Mar 6, 2024 | Direct | F1 |
transaction | STTK | Common Stock | Sale | -$51.5K | -4.9K | -6.17% | $10.53 | 74.4K | Mar 6, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | STTK | Stock Option (Right to Buy) | Options Exercise | $0 | -4.65K | -33.33% | $0.00 | 9.3K | Mar 6, 2024 | Common Stock | 4.65K | $3.51 | Direct | F2 |
transaction | STTK | Stock Option (Right to Buy) | Options Exercise | $0 | -6.46K | -27.08% | $0.00 | 17.4K | Mar 6, 2024 | Common Stock | 6.46K | $3.57 | Direct | F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023. |
F2 | The stock option was granted to the Reporting Person on September 8, 2022, one-third of which vested on September 8, 2023 and the remaining two-thirds of which will vest on September 8, 2024. |
F3 | The stock option was granted to the Reporting Person on January 25, 2023, one-quarter of which vested on January 10, 2024 and the remaining three-quarters of which will vest in approximately equal monthly installments through January 10, 2027. |
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer